Oura's move toward the public markets arrives as the wearable health device sector accelerates its pivot from lifestyle accessory to clinical tool. The company has pursued partnerships with health systems and researchers to validate its biometric data , heart rate variability, body temperature, resp

The FDA's April 30, 2026 proposal to remove semaglutide, tirzepatide, and liraglutide from the 503B outsourcing facility bulks list marks the most consequential regulatory shift in weight management marketing since these drugs entered the mainstream. For the clinics, telehealth platforms, and med sp

A potential gene therapy for lifelong cholesterol management just moved from theoretical to probable, and the implications reach far beyond cardiology wards. Healthcare marketers face a category disruption that will reshape patient acquisition funnels, lifetime value calculations, and the entire pre

Reddit CEO Steve Huffman declared in May 2026 that large language models "would not exist as we know them" without Reddit's user-generated content, calling the platform's data "modern oil" for artificial intelligence . Healthcare marketers should pay attention: The battle over conversational data ha

On April 30, 2026, the FDA approved Auvelity (dextromethorphan hydrobromide and bupropion hydrochloride) for a new indication: treating agitation associated with Alzheimer's disease dementia in adults [1]. The approval is a first of its kind , no non-antipsychotic drug has ever carried this indicati

Tennessee Governor Bill Lee signed the Freedom, Access and Integrity in Registered Pharmacy Act into law in May 2026, making the state the second in the country to prohibit pharmacy benefit managers from owning or operating pharmacies. [1] The law hands CVS Health , which operates both the Caremark

Gilead Sciences secured a rare commercial advantage on May 22, 2026, when the FDA approved Hepcludex (bulevirtide-gmod) as the first treatment for chronic hepatitis delta virus infection in adults—ending a decades-long therapeutic drought for a disease that accelerates liver failure faster than hepa

During May 20, 2026 budget hearings before the Senate Veterans' Affairs Committee and a House Appropriations subcommittee, VA Secretary Doug Collins told lawmakers that the EHR rollout , previously halted and heavily criticized , has turned a corner [1]. VA CFO Richard Topping put concrete numbers t

Quorum CEO Chris Harrison told Becker's Hospital Review that the transaction is expected to close in fall 2026, pending regulatory approval, and will enable the company to operate under significantly reduced debt leverage while redirecting free cash flow into operations [1]. The system plans to depl

The Centers for Medicare & Medicaid Services proposed a rule on May 20, 2026, that would cap state-directed Medicaid payments and align them with Medicare rates , a structural change projected to strip more than $775 billion from Medicaid spending over the next decade, including $510 billion in fede